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ABSTRACT
Computational modelling of mammalian cell cycle
regulation is a challenging task, which requires
comprehensive knowledge on many interrelated
processes in the cell. We have developed a web-
based integrated database on cell cycle regulation
in mammals in normal and pathological states
(Cyclonet database). It integrates data obtained by
‘omics’ sciences and chemoinformatics on the
basis of systems biology approach. Cyclonet is a
specialized resource, which enables researchers
working in the field of anticancer drug discovery
to analyze the wealth of currently available informa-
tion in a systematic way. Cyclonet contains informa-
tion on relevant genes and molecules; diagrams
and models of cell cycle regulation and results of
their simulation; microarray data on cell cycle and
on various types of cancer, information on drug
targets and their ligands, as well as extensive biblio-
graphy on modelling of cell cycle and cancer-related
gene expression data. The Cyclonet database is also
accessible through the BioUML workbench, which
allows flexible querying, analyzing and editing the
data by means of visual modelling. Cyclonet aims
to predict promising anticancer targets and their
agents by application of Prediction of Activity
Spectra for Substances. The Cyclonet database is
available at http://cyclonet.biouml.org.
INTRODUCTION
The main goal of the Cyclonet database is to integrate
information from genomics, proteomics, chemoinformatics
and systems biology on mammalian cell cycle regulation in
normal and pathological states. This will help molecular
biologists working in the ﬁeld of anticancer drug develop-
ment to analyze systematically all these data and generate
experimentally testable hypotheses (Figure 1).
Cyclonetincorporatesdataonvariouscarcinogenesisrelated
topics, such as: cell cycle control in mammals (Figure 2),
cell survival programs (e.g. NF-kB pathway), regulation of
covalent histone modiﬁcations and chromatin remodelling in
cell cycle, DNA methylation and other epigenetic mechanisms
of cell growth and differentiation. Biological pathways,
computer models of cell cycle, microarray data coming from
studies of cell cycle and analysis of cancer-related materials
are also systematically collected in this database (1) (http://
www.impb.ru/~rcdl2004/cgi/get_paper_pdf.cgi?pid=30).
Cyclonet supports discovery of novel drug targets and
development of effective anticancer therapies by collecting
all available data related to the control of cell cycle in
normal and pathological states and providing a system bio-
logy platform for knowledge-based anticancer drug
discovery.
Novel software technologies were used for the database
development:
(i) the BioUML workbench [http://www.biouml.org, (2,3)]
was used for formal description and visual modelling of
biological pathways and processes related to the cell
cycle regulation and cancer (Figure 2). It also allows to
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doi:10.1093/nar/gkl912simulate the behaviour of the described systems using
Java or MATLAB simulation engines;
(ii) BeanExplorer Enterprise Edition (http://www.
beanexplorer.com) was used to develop web interface
for the Cyclonet database (Figure 3).
THE CYCLONET DATABASE STRUCTURE
AND CONTENT
The Cyclonet database consists of three main components
(see Table 1):
(i) diagrams and models of biological pathways (metabolic
pathways, signal transduction pathways and gene
networks) involved in cell cycle regulation and
carcinogenesis;
(ii) microarray original data and results of their statistical
analysis;
(iii) chemoinformatics data—drug targets, ligands and phar-
macological activities for cancer treatment.
The Cyclonet database is organized as a relational database
(MySQL DBMS). All sections contain a number of tables that
are highly interconnected through crossreferences. Such
elaborated relational schema enables complex queries com-
bining various types of information.
Data in Cyclonet are compiled mainly by manual literature
annotation. Links to the public databases, such as, Gene-
Ontology (4), RefSeq (5) and Ensembl (6) are provided
from genes, proteins and other respective entries. Cyclonet
also contains a vast body of literature references that are
arranged by categories.
Figure 1. Diagrams and models of carcinogenesis related processes as the
basis for information integration in the Cyclonet database.
Figure 2. An example of cell cycle model visualization and simulation by the BioUML workbench (the diagram DGR0068a of the Cyclonet database).
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We use BioUML for formal description of signal transduction
pathways and gene networks involved in cell cycle regu-
lation and carcinogenesis (2,3,7). Cyclonet pathways section
allows to store the detailed description of biological pathways,
their components, models as well as the results of simulation.
We are using several diagram types of BioUML to describe
cell cycle regulation and carcinogenesis:
(i) semantic networks describing relationships between the
main concepts (for example, G1 phase, G1/S transition,
mitotic checkpoints) and components of cell cycle
regulation;
(ii) pathways describing structure of cell cycle regulatory
networks as compartmentalized graphs. We have classi-
fied the annotated networks into a number of categories
that describe different parts of cell cycle regulatory
networks in details (for example, a network that provides
G1/S transition, NF-kB signal transduction pathway and
its influence on apoptosis and others).
Models
The BioUML technology was also used for visual modelling
of cell cycle regulation. Known cell cycle models were
imported from SBML (8) and CellML (9) model repositories.
We added into Cyclonet several new recent models by
manual annotation of respective literature sources. We also
created our own novel model of regulation of G1/S transition
of cell cycle.
Currently, Cyclonet contains 37 models of cell cycle regu-
lation. All models can be classiﬁed into two groups:
(i) general models that simulate behaviour of rather small sys-
tems including abstract objects that reﬂect real biological com-
ponents in the cell; (ii) ‘portrait’ models that try to simulate
different sub-processes in cell cycle and include real genes,
proteins and other cellular components. We validated each
model by using the BioUML simulation engine and comparing
the results with the published results. The results of such
simulations were then stored in the Cyclonet database. These
data can be displayed as graphs by the BioUML workbench
(Figure 2) or web isnterface generated by BeanExplorer EE.
Figure 3. Web interface of the Cyclonet database generated by BeanExplorer technology. Top screen displays fragment of microarray series classification in the
Cyclonet database, bottom left screen demonstrates a fragment of the list of pharmacological activities for anticancer therapy, bottom right—examples of
chemical structure of two tubulin antagonists.
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Cyclonet contains a comprehensive list of human genes
which is composed from the genes described in HGNC (10)
and UniGene (11) databases. Cyclonet also contains all
assignment of cDNA clones to the corresponding human
genes.
We analysed 41 microarray resources [mainly, Standford
Microarray Database (12), GEO (13), Oncomine (14) and
published articles, for example, (15)] and obtained
354 links to microarray experimental data related to the cell
cycle and cancer. These links to microarray data were classi-
ﬁed according to cancer types.
Currently data for ﬁve microarray experiments related to
breast cancer and ﬁve experiments with cell cycle time series
were loaded into the Cyclonet database and analysed. We did
a statistical analysis as well as meta-analysis of the data (see
Supplementary Data) and obtained 33 gene lists (IDs
GL0001–GL0033 in ‘Microarray data and results’ of
Cyclonet) that belong to several categories:
(i) lists of genes periodically expressed during cell cycle
(GL0007, GL0020 and GL0021) (15,16);
(ii) lists of genes whose expression is changing mono-
tonically during cell cycle (GL0022) (15,16);
(iii) breast cancer gene lists:
(a) up- and down-regulated genes in each of the five
experiments (GL0001–GL0006, GL0008–GL0018)
(17–21);
(b) up- and down-regulated genes revealed on the basis
of meta-analysis (GL0019, GL0023–GL0033) (22);
(iv) lists of genes obtained by other authors during micro-
array analysis of breast cancer (18–22) and pancreatic
cancer (23).
Such lists of differentially expressed genes are very good
resources for selecting cancer biomarkers as well as perspec-
tive targets for further experimental and bioinformatic anal-
ysis. Statistical methods used in this analysis are described
in Supplementary Data.
Chemoinformatics data
Chemoinformatics section summarizes the current knowledge
about known anticancer targets, anticancer agents, mecha-
nisms of their action and conditions where those compounds
are applied. For this purpose we are collecting the following
information as it is represented in Supplementary Figure 1S:
(i) names of anticancer agents (generic name, brand name)
and its synonyms;
(ii) chemical name;
(iii) CAS number;
(iv) structural formulae;
(v) class (activity)—includes information about molecular
mechanisms of action (e.g. Topoisomerase II inhibitor)
and pharmacotherapeutic action (e.g. Antimetabolite);
(vi) literature references where the data were obtained for the
respective anticancer agent.
Semantic networks provide a reasonable formalism to
describe the relationships between the anticancer agents
and their targets, activities and cancer types (or other condi-
tions) where these agents are generally applied (Figure 4).
Summary statistics of the chemoinformatics section is
shown in Table 1.
INTEGRATION BETWEEN COMPONENTS
OF CYCLONET
Integration between all three components of the Cyclonet
database, namely, biological pathways and models, microar-
ray data and chemoinformatics data, is provided by the fol-
lowing mechanisms:
(i) All data are stored in the same relational database. This
allows us to develop the complex SQL queries to
Table 1. Number of entries for the main blocks (tables, sections) of the
Cyclonet database
Sections of the Cyclonet database Number of
Entries
Biological pathways
Compartments: cellular and organism compartments,
for example, cytoplasm, liver, blood
120
Concepts: biological processes, states, functions etc.
For example, G1 phase, mitosis
987
Genes: list of genes involved in regulation of cell cycle
and related processes
156
Proteins 1942
Reactions 2406
Relations: list of semantic relations (for example, is-a,
part-of, activate) between the pathway components
6137
RNA 30
Substances 485
Diagrams 179
Models 37
Microarray data and result of their analysis
Genes: complete list of human genes compiled as
union of data from HGNC and UniGene databases
45759
Gene crossreferences 181949
Clones: list of human cDNA clones used in cDNA
microarray experiments. It was compiled from
UniGene database
2455666
Information resources: information resources related
with microarray data. For example, SMD, GEO,
Oncomine
41
Microarray experiments: categorized list of
microarray experiments. Each entry contains brief
description of the experiment and links to original
article and primary data
354
Cell cycle 24
Cancer 310
Uploaded microarray experiments: number of cDNA
experiments which primary data were uploaded into
the Cyclonet database
10
Samples 223
Observations 3407624
Gene lists (results of analyses of microarray data) 33
Genes in the lists: total number of genes that were
included in these lists. Note—one gene can be
included into several lists.
17318
Chemoinformatics
Activities: names of molecular mechanisms of action
(e.g. Topoisomerase II inhibitor) and
pharmacotherapeutic action (e.g. Antimetabolite)
201
Structures: structural formulas of drug-like molecules
interacting with the key elements of the cell cycle
4205
Targets: molecular targets interacting with chemical
compounds mentioned above
182
Nucleic Acids Research, 2007, Vol. 35, Database issue D553integrate data from different components. A number of
predefined SQL queries are provided through the web
interface for the Cyclonet database.
(ii) The web interface provides detailed representation (view)
of components of biological pathways, microarray and
chemoinformatics data with a number of crossreferences
between the components. For example, a view for an
anticancer agent contains links to its activities, cancer
types, conditions of its application for anticancer therapy,
components of biological pathways (genes and proteins)
that are targets for this agent. These targets, in turn, can be
linked to diagrams and dynamic models of cell cycle.
Another example is a gene view that contains links to
cDNA clones used for this gene in microarray experi-
ments, microarray experiments where expression level of
this gene was measured, gene lists where this gene was
revealed as result of microarray analyses, anticancer
agentsforwhichthisgeneisatarget,diagramsandmodels
where this gene participates.
(iii) The BioUML search engine allows to find the relationships
between the anticancer agent and biological pathway
components and display these results as an editable graph.
Asastartingpointusercanselecttheanticanceragent(small
molecule), concept, gene or protein.
APPLICATION OF THE CYCLONET DATABASE
Prediction of new anticancer agents for known
targets/mechanisms of action
All anticancer agents are grouped in the Cyclonet database
according to their targets/mechanisms of action and chemical
structure. This information is used for the training of
computer program PASS (Prediction of Activity Spectra for
Substances) (24). As a result of the training procedure, PASS
can predict if new molecules from databases of commercially
available samples may have activities related to the regula-
tion of cell cycle. Three commercially available chemical
compounds’ sample databases were analysed, provided by
ASINEX, ChemBridge and InterBioScreen (IBS). They
contain totally the structures of 1445018 compounds. We
predicted a number of compounds as potential cell cycle
regulators using probability threshold Pa > 70%. By increas-
ing the Pa threshold, e.g. to 90%, one can select highly
speciﬁc compounds only. The results of this analysis are
stored in the Cyclonet database (see the statistics in
Table 2). One may conclude that commercially available
chemical compounds databases contain a plethora of
ligands acting on different targets related to the cell cycle
regulation.
Figure 4. A fragment of semantic network that describes influences of several leads on common targets taking into account different cancer types (conditions).
The diagram DGR0277a in the Cyclonet database.
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Computer simulation methods have been applied to study
the dynamics of gene networks regulating the cell cycle of
vertebrates. The data on the regulation of the key genes
obtained from the Cyclonet database have been used as a
basis to construct gene networks of different degrees of
complexity controlling the G1/S transition, one of the most
important stages of the cell cycle. The behaviour dynamics
of the model has been analysed. Two qualitatively different
functional modes of the system have been obtained. It has
been shown that the transition between these modes depends
on the duration of the proliferation signal. It has also been
demonstrated that the additional feedback from factor E2F
to genes c-fos and c-jun, which was predicted earlier based
on the computer analysis of promoters (25), plays an
important role in the transition of the cell to the S phase (see
Supplementary Figure 2S) as it is documented in gene expres-
sion databases TRANSFAC (26) and TRANSPATH (27).
Application of Cyclonet for searching of new targets for
anticancer therapy
The Cyclonet database can be applied for searching of new
targets for anticancer therapy. For this purpose we have
revealed genes whose expression are signiﬁcantly deregulated
during breast cancer and created a set of diagrams in the
Cyclonet database (diagrams DGR0228–DGR0240) and
mapped information about gene expression into the diagrams.
An example of gene expression data mapping is shown in
Supplementary Figure 3S for a fragment of a diagram of
the proapoptotic network (DGR240).
FURTHER DEVELOPMENT
Now we are developing a set of plug-ins in the BioUML
workbench for visual modelling of integration between the
biological pathways and microarray data that will provide:
coloring of diagrams for biological pathways to display
data on gene expression levels, reconstruction of gene
networks and ﬁtting the model parameters in accordance
with the microarray data. Also, a new information arising
from both ‘omic’-sciences and chemoinformatics is added
periodically to the Cyclonet database, to update its content.
SUPPLEMENTARY DATA
Supplementary data are available at NAR online.
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